Inhibition and activation of c-Src: the head and tail of a coin

Yasuo Fukami1, Tomomi Nagao, Tetsushi Iwasaki

  • 1Department of Biology, Faculty of Science, Kobe University, Nada, 657-8501, Kobe, Japan. yfukami@kobe-u.ac.jp

Insights

Scientists discovered a new way the c-Src kinase is turned on and off. This regulation occurs at the same spot in the kinase, involving peptide or protein interactions, offering insights into broader kinase control mechanisms.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Signaling

Background:

  • Protein-tyrosine kinases (PTKs) are crucial regulators in cellular processes.
  • Src family kinases (SFKs) are well-studied PTKs linked to cell surface receptors.
  • Mechanisms of SFK activation and their regulatory partners remain largely undefined.

Purpose of the Study:

  • To elucidate a novel regulatory mechanism for c-Src, a key member of the SFKs.
  • To investigate how c-Src activity is modulated through specific molecular interactions.
  • To explore the generalizability of this regulatory mode to other kinase families.

Main Methods:

  • Biochemical assays to study c-Src activity.
  • Analysis of protein-protein interactions.
  • Peptide-based interaction studies.

Main Results:

  • A novel mechanism for both inhibition and activation of c-Src was identified.
  • Regulation occurs at a single site within the catalytic domain of c-Src.
  • This regulation is mediated by either peptide or protein-protein interactions.

Conclusions:

  • A new paradigm for kinase regulation involving a shared regulatory site has been uncovered.
  • This mechanism provides insights into the intricate control of Src family kinases.
  • The findings suggest a potentially widespread regulatory strategy applicable to other PTKs and Ser/Thr kinases.

Related Concept Videos

Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...